Aquestive Therapeutics, Inc. (AQST)

NASDAQ: AQST · IEX Real-Time Price · USD

2.420

-0.030 (-1.22%)

At close: Jul 2, 2024, 4:00 PM

2.500

+0.080 (3.31%)

After-hours: Jul 2, 2024, 7:42 PM EDT

Aquestive Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2016
Net Income	-7.87	-54.41	-70.54	-55.78	-66.25	Upgrade
Depreciation & Amortization	1.35	2.39	2.96	3.44	2.91	Upgrade
Share-Based Compensation	2.69	4.38	6.82	6.58	7.07	Upgrade
Other Operating Activities	-2.54	37.82	27.78	0.3	-3.94	Upgrade
Operating Cash Flow	-6.38	-9.82	-32.98	-45.46	-60.21	Upgrade
Capital Expenditures	-1	-1.02	-0.91	-0.52	-0.66	Upgrade
Other Investing Activities	-	-1.5	-	-	-	Upgrade
Investing Cash Flow	-1	-2.52	-0.91	-0.52	-0.66	Upgrade
Share Issuance / Repurchase	17.26	13.62	30.12	6.22	39.32	Upgrade
Debt Issued / Paid	-13.27	-2.03	0	22.34	13.11	Upgrade
Other Financing Activities	-0.01	-0	-0.01	-0.1	-2.83	Upgrade
Financing Cash Flow	3.97	11.59	30.11	28.46	49.6	Upgrade
Net Cash Flow	-3.4	-0.75	-3.78	-17.52	-11.27	Upgrade
Free Cash Flow	-7.38	-10.84	-33.89	-45.98	-60.87	Upgrade
Free Cash Flow Margin	-14.58%	-22.74%	-66.67%	-100.28%	-115.71%	Upgrade
Free Cash Flow Per Share	-0.12	-0.22	-0.89	-1.37	-2.40	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).